Perrigo: ROUNDUP: Perrigo Guides FY25 Well Below Estimates
WASHINGTON (dpa-AFX) - Ahead of its 2025 Virtual Investor Day on Friday, consumer products company Perrigo Co. plc (PRGO) initiated its adjusted earnings, revenue and organic net sales growth guid...
Read full article »
Perrigo is an Ireland-based pharmaceutical company that manufactures and distributes products such as OTC drugs, vitamin supplements, and pediatric nutrition.
Read more